Intco Medical Technology Co

Intco Medical Technology Co Equity

The The Equity of Intco Medical Technology Co (300677.SZ) as of Oct 12, 2026 is 18.25 B CNY. In the previous year, The Equity was 17.40 B CNY — a change of 4.88% (higher).

Equity

18.25 BCNY

YoY

4.88%

Last updated:

In 2025, Intco Medical Technology Co's equity was 18.25 B CNY, a 4.88% increase from the 17.40 B CNY equity in the previous year.

The Intco Medical Technology Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
1.27 B CNY
Jan 1, 2019
1.48 B CNY
Jan 1, 2020
9.34 B CNY
Jan 1, 2021
15.87 B CNY
Jan 1, 2022
15.81 B CNY
Jan 1, 2023
16.03 B CNY
Jan 1, 2024
17.40 B CNY
Jan 1, 2025
18.25 B CNY
The Intco Medical Technology Co Equity history
YEAREquityYoY
18.25 BCNY+4.88%
17.40 BCNY+8.58%
16.03 BCNY+1.41%
15.81 BCNY-0.41%
15.87 BCNY+69.86%
9.34 BCNY+532.49%
1.48 BCNY+16.04%
1.27 BCNY+17.06%
1.09 BCNY+103.10%
535.45 MCNY+28.96%
415.19 MCNY+146.59%
168.38 MCNY—
Access this data via the Eulerpool API
Get Free API Key

Intco Medical Technology Co Stock analysis

What does Intco Medical Technology Co do? Intco Medical Technology Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Intco Medical Technology Co's Equity

Intco Medical Technology Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Intco Medical Technology Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Intco Medical Technology Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Intco Medical Technology Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Intco Medical Technology Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Intco Medical Technology Co stock

The Equity of Intco Medical Technology Co is 18.25 B CNY in 2025.

The Equity of Intco Medical Technology Co changed from 17.40 B CNY to 18.25 B CNY, representing a 4.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Intco Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Intco Medical Technology Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Intco Medical Technology Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Intco Medical Technology Co